PHAXIAM Therapeutics S.A.

DB:2E40 Stock Report

Market Cap: €15.9m

PHAXIAM Therapeutics S.A. Company Information

PHAXIAM Therapeutics S.A.'s employee growth, exchange listings and data sources


Key Information

  • Name: PHAXIAM Therapeutics S.A.
  • Ticker: 2E40
  • Exchange: DB
  • Founded: 2004
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: €15.921m
  • Shares Outstanding: 10.01m
  • Website: https://www.phaxiam.com

Number of Employees


Location

  • PHAXIAM Therapeutics S.A.
  • 60 Avenue Rockefeller
  • Bâtiment Adénine
  • Lyon
  • Rhône-Alpes
  • 69008
  • France


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PHXMENXTPA (Euronext Paris)YesCategory O SharesFREURApr 2013
PHXMPBATS-CHIXE (BATS 'Chi-X Europe')YesCategory O SharesGBEURApr 2013
0QSSLSE (London Stock Exchange)YesCategory O SharesGBEURApr 2013
2E40DB (Deutsche Boerse AG)YesCategory O SharesDEEURApr 2013

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/29 11:05
End of Day Share Price 2024/11/28 00:00
Earnings2024/06/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.